• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.43 Down 0.00(1.12%) Apr 24, 3:59PM EDT
    Add to Portfolio
    Prev Close:0.44
    Open:0.44
    Bid:0.38 x 3000
    Ask:0.47 x 4000
    1y Target Est:4.00
    Beta:2.54
    Earnings Date:May 12 - May 18 (Est.)
    Day's Range:0.43 - 0.44
    52wk Range:0.40 - 1.75
    Volume:381,225
    Avg Vol (3m):459,287
    Market Cap:12.27M
    P/E (ttm):N/A
    EPS (ttm):-0.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXADown 1.12%12.27M
    SNYDown 0.02%135.32B
    TEVAUp 1.83%54.87B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Mar-15) :-0.15
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback